Particle Tracing Based on 4D Flow Magnetic Resonance Imaging: A Systematic Review into Methods, Applications, and Current Developments
Abstract
Background
Particle tracing based on 4D Flow MRI has been applied as a quantitative and qualitative postprocessing technique to study temporally evolving blood flow patterns.
Purpose
To systematically review the various methods to perform 4D Flow MRI-based particle tracing, as well as the clinical value, clinical applications, and current developments of the technique.
Study type
The study type is systematic review.
Subjects
Patients with cardiovascular disease (such as Marfan, Fontan, Tetralogy of Fallot), healthy controls, and cardiovascular phantoms that received 4D Flow MRI with particle tracing.
Field Strength/Sequence
Three-dimensional three-directional cine phase-contrast MRI, at 1.5 T and 3 T.
Assessment
Two systematic searches were performed on the PubMed database using Boolean operators and the relevant key terms covering 4D Flow MRI and particle tracing. One systematic search was focused on particle tracing methods, whereas the other on applications. Additional articles from other sources were sought out and included after a similar inspection. Particle tracing methods, clinical applications, clinical value, and current developments were extracted.
Statistical Tests
The main results of the included studies are summarized, without additional statistical analysis.
Results
Of 127 unique articles retrieved from the initial search, 56 were included (28 for methods and 54 for applications). Most articles that described particle tracing methods used an adaptive timestep, a fourth order Runge–Kutta integration method, and linear interpolation in the time dimension. Particle tracing was applied in heart chambers, aorta, venae cavae, Fontan circulation, pulmonary arteries, abdominal vasculature, peripheral arteries, carotid arteries, and cerebral vasculature. Applications were grouped as intravascular, intracardiac, flow stasis, and research.
Data Conclusions
Particle tracing based on 4D Flow MRI gives unique insight into blood flow in several cardiovascular diseases, but the quality depends heavily on the MRI data quality. Further studies are required to evaluate the clinical value of the technique for different cardiovascular diseases.
Evidence Level
5.
Technical Efficacy
Stage 1.
Cardiovascular disease (CVD) is the leading cause of death worldwide, with approximately 18 million lives lost every year.1 The prevalence of acquired CVD is increasing, especially in patients aged below 50 years of age.2 Furthermore, congenital CVD is the most common congenital defect in newborn babies and the number of patients surviving with congenital CVD has greatly increased, due to advances in diagnosis and in pre-peri and post-operative care, although complications can occur later in life and may only be found during long-term follow-up.3
The most important factors for improving CVD outcomes are early detection, correct diagnosis, and adequate management of interventions during long-term follow-up.4 It is crucial to study the development of CVD individually for each patient to choose the correct treatment, but there are not many accurate (sub)clinical markers that are useful for follow-up.4, 5 Blood flow patterns are among the mechanisms linked to (dys-)function of the myocardium, valves, and vessels.4 Understanding these blood flow patterns and recognition of aberrant flow may contribute to improved diagnostic and prognostic accuracy for CVDs and may support early detection of subclinical disease or early recognition of complications.
Cardiovascular magnetic resonance imaging (in short: cardiac MRI) is an imaging technique that can noninvasively assess the function and structure of the cardiovascular system by generating time-resolved visualizations of the blood flow within the heart and vessels.6 Cardiac MRI gives a unique insight into the cardiovascular function without the risks associated with cardiac catheterization or x-ray based imaging. Four-dimensional (4D) Flow MRI has emerged as a cardiac MRI technique that combines three-dimensional (3D) spatial cine imaging with three-directional velocity-encoding phase-contrast MRI, enabling the analysis of the temporal evolution of blood flow patterns within a 3D volume.7 These 4D Flow MRI scans result in large amounts of velocity data that can be visualized with pathlines or streamlines visualization, but also with streaklines, vector plots, (nested) isosurfaces and volume rendering as demonstrated in Fig. 1.8

Particle traces are lines that show the path virtual particles follow throughout a velocity field.8 In a time-varying velocity field, these particle traces are called pathlines. Comparatively, streamlines are paths that are everywhere tangent to the velocity vectors at a specific point in time.9 Streamlines are therefore paths virtual paths would take in nontime-varying velocity fields, such as a single timepoint of the 4D Flow MRI data, and they can also be calculated with particle tracing.9 In cardiac MRI, these particles and their pathlines represent small volumes of blood and their path throughout the cardiovascular structure, respectively. Pathlines are especially useful in unsteady velocity fields in which the flow changes over time, such as the pulsatile human blood flow.10 Streamlines indicate the direction of flow at specific moments during the cardiac cycle but do not reflect the path blood actually follows over time.9 The technique of following particles is called particle tracing or tracking. Besides visualization, this technique may also be used to quantify blood flow and flow patterns.8 Particle tracing may be a useful diagnostic tool to evaluate patients with CVD, but it has not yet been widely applied. While there is literature describing the clinical value of particle tracing, this is inherently limited by inaccuracies in the acquired data sets and the postprocessing technique itself.6, 8, 10
The present systematic review investigates current literature on the various methods applied to perform 4D Flow-based particle tracing. Furthermore, the clinical value and the clinical applications of the technique are reviewed and advice on how to perform these clinical analyses will be presented. Finally, current developments of the technique will be discussed.
Methods
Search Strategy and Inclusion Criteria
- Abstracts referencing 4D Flow MRI-based particle tracing.
- Full texts describing particle tracing methods, for example, settings and software used, and an accuracy measurement.
- Abstracts referencing 4D Flow MRI applied in the cardiovascular system.
- Full texts include particle tracing being applied for visualization or quantification.
Current developments were identified in the discussion sections of each included article. Additional search queries were performed in Google Scholar with similar search strategies as previously mentioned, to include literature not listed in the PubMed database. Literature on non-MRI-based flow field particle tracing techniques, such as computational fluid dynamics (CFD) based particle tracing, was retrieved to provide a summary of the technical background of particle tracing.
Data Analysis
From the included literature, methods of particle tracing, applications of particle tracing, and the current developments of the technique were summarized. Clinically significant findings that were produced by particle tracing and delineated the clinical value of the technique were reported.
Results
Included Articles
A total of 54 articles (of which 1 for methods and 54 for applications) were selected from 127 unique articles after screening (Fig. 2). After exclusion of articles for particle tracing methods based on the inclusion criteria, only one article mentioned both precise particle tracing methods and an accuracy measurement. This prevents the original goal of this review to compare particle tracing methods and their outcomes. We therefore summarized the methods of 28 articles before applying the second inclusion criteria in the following sections, increasing the total number of included articles to 56 (Fig. 2). The 54 articles that were identified from the second search strategy and their main outcomes based on particle tracing are summarized in the application sections. Table 1 summarizes the included articles.

Included reference (reference number) | Method search strategy | Applications search strategy | Software | Integrator | Timestep | Interpolation | Accuracy | Circulation |
---|---|---|---|---|---|---|---|---|
Bächler et al, 2013, Radiology12 | - | Ext | - | - | - | - | - | Fontan |
Bächler et al, 2013, Magn Reson Imaging13 | - | Yes | - | - | - | - | - | Pulmonary |
Bammer et al, 2007, Magn Reson Med14 | Yes | Yes | Ensight | RK4 | Adapt | Linear time | - | Intracranial |
Bastkowski et al, 2019, Radiol Cardiothorac Imaging15 | - | Yes | - | - | - | - | - | Fontan |
Bieging et al, 2011, J Magn Reson Imaging16 | - | Yes | - | - | - | - | - | Aorta |
Bolger et al, 2007, J Cardiovasc Magn Reson17 | Ext | Ext | Ensight | RK4 | Adapt | Linear time | - | LV |
Bunck et al, 2012, Eur J Radiol18 | Ext | Yes | GTFlow | - | - | - | Yes | Peripheral |
Calkoen et al, 2014, J Thorac Imaging6 | Yes | Yes | - | - | - | - | - | Intracardiac, Thoracic |
Calkoen et al, 2015, Invest Radiol19 | Yes | Yes | - | RK4 | - | - | Yes | LV |
Carlsson et al, 2011, J Cardiovasc Magn Reson20 | Yes | Yes | Ensight | RK4 | Adapt | Linear time | Yes | Intracardiac |
Costello et al, 2018, Int J Cardiovasc Imaging21 | Yes | Yes | MATLAB | - | - | - | - | Ventricles |
Dyverfeldt et al, 2011, J Magn Reson Imaging22 | Yes | Yes | Ensight | RK4 | Adapt | Linear time | - | LA |
Eriksson et al, 2011, Am J Physiol Heart Circ Physiol23 | Ext | - | - | - | - | - | - | LV |
Eriksson et al, 2010, J Cardiovasc Magn Reson24 | Ext | - | - | RK4 | Adapt | - | Yes | LV |
Föll et al, 2013, Eur Heart J Cardiovasc Imaging25 | - | Yes | - | - | - | - | - | LV |
François et al, 2012, J Cardiovasc Magn Reson26 | Yes | Yes | Ensight | RK4 | Adapt | Linear time | - | Fallot (RV, PA) |
Friman et al, 2011, Med Image Anal27 | Yes | Yes | MeVisLab | RK4 | Voxel size | Linear | - | Aorta, Carotids |
Friman et al, 2010, Med Image Comput Comput Assist Interv28 | - | Yes | - | - | - | - | - | Aorta |
Frydrychowicz et al, 2012, Eur Radiol29 | - | Yes | - | - | - | - | - | Aorta |
Frydrychowicz et al, 2009, Interact Cardiovasc Thorac Surg30 | - | Yes | - | - | - | - | - | Aortic Graft |
Frydrychowicz et al, 2007, J Magn Reson Imaging31 | - | Yes | - | - | - | - | - | Peripheral |
Frydrychowicz et al, 2008, J Cardiovasc Magn Reson32 | Yes | Yes | Ensight | RK4 | Adapt | Linear time | - | Aorta |
Fyrenius et al, 1999, J Am Soc Echocardiogr33 | - | Yes | - | - | - | - | - | LV |
Fyrenius et al, 2001, Heart34 | Yes | Yes | - | - | - | - | - | LA |
Gaeta et al, 2018, Magn Reson Imaging35 | Yes | Yes | MATLAB | RK4 | 5 ms | - | - | LA |
Geiger et al, 2011, Eur Radiol36 | - | Yes | - | - | - | - | - | Fallot (PA, Aorta) |
Geiger et al, 2012, J Magn Reson Imaging37 | - | Yes | - | - | - | - | - | Aorta |
Giese et al, 2014, J Cardiovasc Magn Reson38 | Yes | Yes | GTFlow | - | - | - | - | Thoracic |
Hussein et al, 2020, 3D Print Med39 | - | Yes | - | - | - | - | - | Heart valve phantom |
Kamphuis et al, 2018, J Magn Reson Imaging40 | Yes | Yes | MASS (inhouse) | RK4 | 8 ms | - | Yes | Intracardiac |
Kanski et al, 2015, BMC Med Imaging41 | Yes | Yes | - | RK4 | 5 ms | Linear | - | Intracardiac |
Lorenz et al, 2014, Magn Reson Med42 | Yes | Yes | Ensight | RK4 | Adapt | Linear time | Yes | Aorta, intracranial, phantom |
Markl et al, 2005, J Thorac Cardiovasc Surg43 | - | Yes | - | - | - | - | - | Aorta |
Markl et al, 2004, J Comput Assist Tomogr44 | - | Yes | - | - | - | - | - | Aorta |
Morbiducci et al, 2009, Ann Biomed Eng45 | - | Yes | - | - | - | - | - | Aorta |
Neuhaus et al, 2019, J Cardiovasc Magn Reson46 | Yes | Yes | - | - | - | - | Yes | Aorta |
Nilsson et al, 2013, Acta Radiol47 | Yes | Yes | GTFlow | - | - | - | Yes | Phantom |
Reiter et al, 2013, PLoS One48 | Yes | Yes | - | - | - | - | - | Pulmonary |
Richter et al, 2021, Magn Reson Med49 | - | Yes | - | - | - | - | - | Aorta |
Rijnberg et al, 2019, Eur J Cardiothorac Surg50 | - | Ext | - | - | - | - | - | Fontan |
Rijnberg et al, 2021, J R Soc Interface51 | - | Ext | - | - | - | - | - | Fontan |
Schäfer et al, 2021, J Am Heart Assoc52 | Yes | Yes | CVI42 | - | - | - | - | Ventricles |
Schäfer et al, 2020, J Thorac Cardiovasc Surg53 | Ext | Ext | - | - | - | - | - | Fallot (LV) |
Schrauben et al, 2019, J Cardiovasc Magn Reson54 | - | Yes | - | - | - | - | - | Aorta, heart, fetal sheep |
Stankovic et al, 2015, Eur Radiol55 | - | Yes | - | - | - | - | - | Abdomen |
Stankovic et al, 2013, Eur J Gastroenterol Hepatol56 | - | Yes | - | - | - | - | - | Abdomen |
Stankovic et al, 2014, Magn Reson Med57 | - | Yes | - | - | - | - | - | Abdomen |
Stankovic et al, 2010, J Magn Reson Imaging58 | - | Yes | - | - | - | - | - | Abdomen |
Stankovic et al, 2015, MAGMA59 | - | Yes | - | - | - | - | - | Abdomen (liver) |
Töger et al, 2011, BMC Med Imaging60 | Yes | Yes | Ensight | RK4 | Adapt | Linear time | - | LV |
Viola et al, 2020, J Magn Reson Imaging61 | Yes | Yes | - | - | - | - | Yes | LV, Aorta |
Weigang et al, 2008, Eur J Cardiothorac Surg62 | Yes | - | - | - | - | - | Aorta | |
Wigström et al, 1999, Magn Reson Med63 | Yes | Yes | Ensight | RK4 | Adapt | Linear time | - | Intracardiac |
Wong et al, 2018, J Appl Physiol64 | - | Yes | - | - | - | - | - | LV |
Yamashita et al, 2007, J Magn Reson Imaging65 | - | Yes | - | - | - | - | - | Intracranial |
Ziegler et al, 2019, Magn Reson Imaging66 | Yes | Yes | MATLAB | RK4 | 5 ms | - | - | Aorta |
- Adapt = Adaptive (timestep); Ext = External source; LA = Left atrium; LV = Left ventricle; PA = Pulmonary artery; RK4 = Fourth-order Runge–Kutta; RV = Right ventricle.
- Software: CVI42 (Circle Cardiovascular Imaging Inc., Calgary, Canada), Ensight (ANSYS Inc., Canonsburg, USA), GTFlow (GyroTools LLC, Zurich, Switzerland), MATLAB (Mathworks, Natick, USA), MASS (Leiden University Medical Center, Leiden, The Netherlands), MeVisLab (MeVis Medical Solution AG, Bremen, Germany).
Principles of Particle Tracing
Particle tracing was developed to visualize flow in fluid dynamics and aerodynamics.67 Originally, small particles such as grain, dye or smoke were added to fluid or air flows to visualize the internal flow patterns of a larger stream. Tracking the small particles and analyzing the characteristics of their path is the basic principle of particle tracing. Nowadays, particle tracing can be done digitally in computational fluid dynamics, computational aerodynamics, or cardiovascular imaging. Other visual methods including particle imaging velocimetry have been developed.
- The velocity vector is four-dimensionally interpolated from the MRI velocity data.27, 41
- The flow velocity and direction are integrated over a specified timespan (timestep) to calculate the displacement of the particle within that time span.68
- The new spatiotemporal (4D) location of the particle is calculated (Fig. 3). These steps are then repeated until a user-specified stopping condition is met.

As mentioned in step 3, particles are traced until a stopping condition is reached. These stopping conditions can be chosen by the user and may include a maximum particle travel distance, minimum particle velocity, leaving the structure-of-interest (3D model), maximum angle to previous trace segment, among others.
When particle tracing is complete, the particle path can be visualized as the so-called pathlines or streamlines, determined by whether the velocity data are time varying or not, respectively. Pathlines show the path of each particle over time (Fig. 3) and therefore constant or evolving flow patterns. Streamlines show the hypothetical path of each particle at a point in time and may therefore show temporary flow patterns. The pathlines can be drawn per timepoint in the 4D velocity data (timeframe) and combined in cine mode to form an animation. Color coding can be used to simplify the visual differentiation of individual particles and to add information such as particle origin, particle velocity per particle trace segment, or distance traveled (Fig. 4a–c, respectively). The number of particles traversing a structure of interest in a specific time period (i.e. flow volumes) can also be quantified and, for example, specified by categorizing the particles based on their origin or destination.24

DISCRETE INTEGRATION
After seeding the particles, each particle trace is calculated by integrating the velocity data. This is done using discrete integration, also called stepwise integration (Fig. 3). While the simplest discrete integration method, the Euler method, is very computationally inexpensive, it is also less accurate than more computationally expensive methods.68, 69 Popular methods are the Runge–Kutta methods, which are a family of higher-order methods that include the Euler method.68, 70 The most-used method is the fourth order Runge–Kutta method (RK4), which was applied in all 15 included articles that reported the integration method used.14, 19, 20, 22, 24, 26, 27, 32, 35, 40-42, 60, 63, 66 The second-order Runge–Kutta method (RK2) might also be sufficiently accurate for particle tracing while less computationally expensive.68
This discrete integration is done over small steps in time. The length of this timestep is an important setting in particle tracing and largely defines the quality of the technique.68 The optimal timestep length is predominantly dependent on the temporal resolution of the velocity data but also the spatial resolution, maximum velocity, and size of the structure of interest. The integration can also be performed using adaptive Runge–Kutta methods that change the timestep dynamically based on an error estimation, which may decrease overall computation time, but the maximum timestep should be chosen carefully to prevent quality loss.71 Of the 28 articles included for particle tracing methods, only 14 specified the timestep used. Nine of these used an adaptive Runge–Kutta method with a dynamic timestep,14, 20, 22, 24, 26, 32, 42, 60, 63 while the other five used a fixed time of 5 msec,35, 41, 66 8 msec40 or a specifically chosen size so the spatial length each step is of the same order as the grid resolution.27
INTERPOLATION
In the case of 4D Flow MRI data, the velocity data have the characteristics of a structured rectilinear grid, where the distance between the grid points is equal to the voxel size and the temporal resolution. The velocity data can be interpolated to find the velocity of a particle moving between the fixed grid-points. This interpolation can be done using simple computationally inexpensive methods, such as linear interpolation, or using more advanced methods such as cubic interpolation.72 In all 10 included articles that reported on interpolation, it was performed using linear interpolation in the time dimension and tri-linear or tri-cubic (or other shape-function) interpolation in the space dimensions.14, 20, 22, 26, 27, 32, 41, 42, 60, 63 For comparison, in high-quality CFD data, more advanced interpolation methods such as b-spline are advised.73
ACCURACY
The settings used to perform particle tracing have an effect on how accurate and how computationally expensive the technique is. However, because only one article40 reported both the exact methods of 4D Flow-based particle tracing and quantitatively assessed the accuracy, it is impossible to investigate the optimal methods based on the current literature beyond the most commonly used setting described previously. Additionally, settings advised for CFD-based particle tracing may not be suitable for 4D Flow-based particle tracing due to the differences in data quality and spatiotemporal resolution. It is therefore advised to experiment with different settings for different 4D Flow data and to always assess the accuracy, for example, by measuring the fraction of particles that wrongfully leave the cardiovascular structure through the structure wall.6
The accuracy of particle tracing is also greatly dependent on the quality of the 4D Flow data. Due to the stepwise nature of particle tracing, errors caused by noise may accumulate and result in inaccurate particle traces.27 Noise may cause an inaccurate location to be calculated in the integration step, which is then used in the next integration step. It is therefore advised to perform 4D Flow MRI acquisition according to the current consensus statement to prevent artifacts and increase the signal-to-noise ratio.8 Additionally, 4D Flow MRI data can be influenced by different phase offset errors such as Eddy currents, Maxwell terms, and Gradient field inhomogeneity phase offset errors. Correcting for these phase offset errors can lead to more reliable particle tracing, especially in data acquired with a low encoding velocity and higher-order background correction.42, 47, 61
Due to the dependency of particle tracing on the quality of the data, particle tracing outcomes can be used as an quality assessment for different 4D Flow MRI sequences20, 59 and postprocessing techniques,42, 47, 61 or new applications of 4D Flow MRI, such as abdominal vasculature55, 56 and peripheral stents.18
In all literature included, massless particles are traced. Blood is a nonhomogeneous fluid with cells of different sizes, and massless-particle tracing is an oversimplification of the distribution of actual cells. Massed-particle tracing might be more accurate, by including more physical properties such as inertia. Unfortunately, no literature comparing massless- to massed-particle tracing in medical data could be found.
SEEDING STRATEGIES
The method of where and when to seed (release) the virtual particles in the velocity data determines the analysis that can be performed with particle tracing. Therefore, the desired outcomes must be determined first, and the seeding strategy should be derived from that. The precise seeding strategies for common applications are described in the respective application sections below.
Particle tracing can be performed forward in time or backward in time (by using a negative timestep in the integration or by inverting the velocity vectors of the data) to calculate their destination or origin, respectively.6, 63 Therefore, particles should be seeded either just before entering or just after exiting the structure of interest.6, 9 Alternatively, if the origin or destination of a specific volume of blood is of interest, particles can be seeded in the volume itself, for example, in each voxel, a uniform 3D grid, or with a random distribution.24, 63
Seeding can be done instantaneously at one point in time, or continuously at a defined interval for a period.51, 63 The instantaneous method can be useful for following a specific volume of blood through the cardiovascular structure. Continuous seeding can be used to assess the entire flow over a specific time period, but this can be difficult to visualize. However, this can also be used to create streaklines, a visualization method notably different from pathlines and streamlines.
To ensure the particles released from a 2D grid represent an equal volume of blood, Gaeta et al have developed an optimized seeding method by adjusting the time interval between releasing particles from the same location.35 This may be especially useful for correct quantification of flow distributions and component analyses in atria, as described below.
Applications
4D Flow MRI-based Particle tracing can visualize the temporal evolution of the blood flow in the acquired structure. The optimal algorithm settings, seeding strategy, and clinical value depend on the structure of interest and the MRI acquisition parameters. The resulting visualization of the flow gives insight into the efficiency of the cardiovascular structure in a way that is easy to understand and is therefore intuitive to people with various degrees of medical or technical knowledge, such as engineers, physicians, and patients.5, 8 Furthermore, particle tracing can be used for quantification of flow phenomena, such as flow distributions or the number and size of vortices or helices.
We included 53 articles that performed particle tracing in 4D Flow MRI of the following anatomies: heart chambers, thoracic and abdominal aorta, venae cavae, Fontan circulation, pulmonary arteries, the abdominal vasculature including the portal vein, peripheral arteries, the carotid arteries as well as the cerebral vasculature. The following sections describe each application and are grouped and preceded by the methods used.
INTRAVASCULAR PARTICLE TRACING
In major arteries and veins, such as the aorta, intravascular particle tracing can be applied. Commonly, a seeding grid is placed at the inlet of the cardiovascular structure of interest, for example, near the aortic root. Particles are then seeded instantaneously at the beginning of systole or diastole or continuous for a specific duration, such as an entire cardiac cycle (Fig. 5a). This is often done from seeding grids, which are placed near the proximal start of the vessel of interest. Multiple grids may be needed for complete visualization of the vessel due to the loss of particles as described above. After seeding and tracing, pathlines and streamlines can be observed for abnormal flow patterns, such as the appearance of helical or vortical flow structures (Fig. 5b,c). Alternatively, backwards intravascular particle tracing can be used to determine the origin of the blood flow. Seeding particles instantaneously or continuously can highlight a specific part of the cardiac cycle or a longer temporal interval, respectively.

In branching vessels, particle tracing can be used to quantify the distribution of flow by assessing the origins and destinations of particles. These flow distributions are especially useful in determining flow through shunts and complex anatomies, such as the total cavopulmonary connection in Fontan patients, as explained further below.
Blood flow in major vessels may contain (almost) permanent vortices and areas with recirculating flow, aside from the otherwise near-laminar flow. Particles seeded proximal to this vortex may follow the laminar flow around the vortex and the vortex will not be visualized or quantified by pathlines (Fig. 6a). A workaround could be localizing vessel volumes with decreased pathline density and subsequently seeding in these less dense volumes to visualize the vortices (Fig. 6c). Alternatively, other visualization methods such as streamlines or quantification methods such as vortex quantification may be employed to find these abnormal blood flow patterns (Fig. 6b).

AORTA
Normal flow patterns in the thoracic aorta have been investigated with particle tracing and include right-handed helical outflow, late systolic retrograde flow, and accelerated passage through the aortic valve plane.44, 45 Particle tracing can distinguish between healthy volunteers and patients with thoracic aortic disease, including ascending aortic aneurysms, aortic regurgitation, and aortic dissection.44 However, it is worth noting that flow patterns in the aortic arch, and maybe the entire aorta, are also related to age and ascending aorta diameter, as demonstrated with particle tracing.29 To decrease acquisition times, 4D Flow MRI acquisition acceleration techniques, such as compressed-sensing or a waive-CAIPI, have been shown to be feasible in the assessment of aortic flow with particle tracing.46, 49
Bicuspid aortic valve (BAV) is a congenital heart disease in which the aortic valve consists of only two cusps instead of three. This results in a decreased aortic valve aperture, an increase in blood velocity through the aortic valve, and increased wall shear stresses in the ascending aorta. It is often symptomless until adulthood and can cause other pathologies such as aortic valve stenosis (which may lead to congestive heart failure), regurgitation, and aortic aneurysm, with increased risk of aortic dissection. Using 4D Flow MRI-based particle tracing and other flow-based quantifications, helical flow patterns, increased wall shear stress and flow displacement in the ascending aorta are often present in patients with BAV.74 Helical flow patterns in the ascending aorta are also related to ascending aorta dilation, which may occur with BAV.16
Aortic coarctation, a narrowing of a segment of the aorta, is a common birth defect with an overall incidence of 5%–8% of all congenital cardiac defects.75 This defect typically occurs at the junction of the aortic arch and descending aorta. Coarctation is associated with other cardiovascular abnormalities including bicuspid aortic valve, arch hypoplasia, intracardiac shunts, and subaortic stenosis.76 During systole, abnormal blood flow patterns such as vorticity and helicity can be observed in the aorta distal to the coarctation, which can also occur after coarctation repair and may be associated with the development of systemic hypertension.75
FONTAN CIRCULATION
Children with a univentricular heart defect represent the most severe end of the spectrum of congenital heart disease. The Fontan procedure is the palliative treatment of choice for these patients, in which both the superior and inferior vena cava are directly connected with the pulmonary arteries, the so-called total cavopulmonary connection (TCPC).77 Therefore, the TCPC is characterized by a cross-like shaped structure, in which opposing caval blood flow results in complex and heterogeneous blood flow patterns. Regular assessment of blood flow within this structure is important for early detection of inefficient flow patterns and flow distributions that may benefit from additional intervention (such as pulmonary artery stenting).78, 79
Particle tracing provides unique insights for the cardiologist and cardiac surgeon to assess the complex blood flow, its distribution, and the possible necessity and approach of additional surgical corrections in patients with a Fontan circulation.10, 80, 81 Abnormal blood flow can be discovered with pathlines visualization and the accompanying viscous energy loss can subsequently be quantified, as shown in inferior vena cava-Conduit mismatch.50 Furthermore, particle tracing is used quantitatively to calculate the hepatic flow distribution (HFD), by determining the distribution of conduit flow, containing hepatic venous flow, toward the left and right pulmonary arteries (Fig. 7b). Hepatic venous flow contains an important “hepatic factor” that is needed in both lungs to prevent the formation of pulmonary arteriovenous malformations.12, 82 This quantitative measurement can only be performed with particle tracing and might identify patients at risk of pulmonary arteriovenous malformations.12

To calculate the HFD, particles are seeded continuously for the duration of one heart cycle from two seeding grids, one in the inferior vena cava and one in the superior vena cava (Fig. 7b). The particles are then traced until all have left the TCPC. Then, the fractions of the particles that have left through the left pulmonary artery, the right pulmonary artery, or through the TCPC wall (missing particles) are calculated. This type of flow distribution quantification can be applied to any bifurcating vasculature (Fig. 7a). For merging vasculature, seeding grids may be placed in the converged vessel and particles can be traced backwards to quantify the contribution of each connecting vessel.
Unfortunately, the accuracy of the HFD is limited by the spatial resolution and velocity noise. A lost particle fraction of around 20% was suggested as a cutoff condition, as the accuracy is otherwise too low to use clinically.83 Unfortunately, the lost particles fraction and their effect on the clinical value of the measurement are often not reported or unknown. Figure 7b shows an example of the mixing of particles coming into the TCPC from the venae cavae and leaving through the pulmonary arteries. TCPC conduit flow is tracked as a surrogate marker of hepatic venous flow in most studies, as a uniform distribution of hepatic venous flow at the level of the conduit is often assumed, but this is not the case in most patients as shown with particle tracing.51
Flow distributions of flow originating from the venae cavae in patients with Fontan circulation and flow originating from the pulmonary trunk in healthy volunteers have been investigated using particle tracing in a 5D Flow study (4D + Respiration).15 In this study, four 4D Flow datasets were reconstructed from a single acquisition, each set derived from data acquired during different part of the respiratory cycle (end-expiration, inspiration, end-inspiration, and expiration). Flow distributions to the pulmonary arteries were more respiratory dependent in patients with Fontan circulation than in healthy volunteers, especially caused by an important increase in hepatic venous flow during inspiration.15, 84 4D Flow MRI acquisition may not be feasible in young patients due to long scan times and possible motion artifacts, but high acceleration factors for acquisition have been shown to have good results in Fontan patients.38
PULMONARY CIRCULATION
In a study by Bächler et al to determine the normal flow patterns in the pulmonary circulation, it was shown that helical flow is normally present in the main pulmonary artery (PA) and right PA.13 Specifically, two counter-rotation helices were found in the main PA and in some volunteers right-handed helical flow in the right PA as well. The helical flow was absent or substituted by abnormal vortical flow in the main PA in a patient with corrected transposition of great arteries or partial anomalous pulmonary venous return and atrial septal defect, respectively.
Pulmonary hypertension, defined as elevated mean pulmonary arterial pressure (mPAP, >25 mmHg at rest or >30 mmHg during exercise), is associated with vortical flow in the main PA.85 Diagnosing pulmonary hypertension with vortex persistence based on particle tracing and pathline visualization had an area under ROC curve of 0.998, but this was similar for 3D vector, multiplanar reformatted vector and streamline visualization.48 Correlation between vortex persistence and elevated mPAP was r = 0.92, meaning that particle tracing can be used for accurate diagnosis of pulmonary hypertension and estimation of elevated mPAP.48
ABDOMINAL VASCULATURE
In two abdominal 4D Flow feasibility studies, particle tracing was used to visualize blood flow in a number of vessels in the splanchnic and portal arterial and venous vasculature.56, 58 Feasibility was judged on the visibility of the vessels in pathline visualization, which highlights the application of particle tracing for studying feasibility in new applications of 4D Flow MRI. Feasibility was shown to be good, but in a subsequent reproducibility study, a higher spatiotemporal resolution (than 2.4 × 2.0 × 2.4 mm3, 61.2 msec) was recommended for complete assessment of the hepatic blood flow.57 Changes in portal and splanchnic arterial hemodynamics in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) have been assessed using 4D Flow MRI.55 Postoperatively increased flow rates in the portal vein, hepatic artery and in splenic and superior mesenteric arteries were identified and visualized with particle tracing.
CAROTID ARTERIES AND INTRACRANIAL VASCULATURE
Flow in smaller vessels, such as the intracranial arteries can be measured with 4D Flow MRI if the spatial resolution is sufficiently high enough. In an observational study to further understand the in vivo hemodynamics of the carotid arteries, particle tracing was used to assess the velocity profile and it was shown that this is parabolic (with a Womersley profile).65 Furthermore, intracranial arterial flow was shown to be laminar. In another study concerning the use of acceleration techniques in cerebral 4D Flow MRI, the use of particle traces was advised to assess risk of plaque formation and progression and to assess flow dynamics and vascular patency before and after vascular interventions.14
PERIPHERAL VASCULATURE
Using particle tracing, Iliac and proximal femoral artery blood flow is shown to be laminar without flow accelerations or disturbances, which is in agreement with ultrasound findings.31 In a patient with peripheral arterial occlusive disease, multiple flow accelerations could be identified and complex helical flow was observed distal to a moderate stenosis.31 These findings are promising for the clinical value of the technique, but further studies comparing particle tracing in peripheral vasculature to standard diagnostic tools are needed.
Stents may be used in the treatment of occluding peripheral vessels but can significantly complicate MRI by stent associated artifacts. 4D Flow-based particle tracing for in-stent flow visualization has been assessed for 17 different peripheral stents and was shown to be feasible for 14 of the stents.18 Particle tracing may therefore be used for assessing prestent and poststent peripheral hemodynamics.
FLOW STASIS
Flow stasis can occur in aneurysms and is often analyzed using contrast agents in MRI but can also be done using particle tracing by measuring the residence time of the particles.66 Important limitations are the accumulation of errors during extended particle tracing, which is necessary for this type of measurement, and the low velocity-to-noise ratio in areas with low velocities, such as areas with flow stasis. Measures such as particle travel distance analysis (TDA) and mean velocity analysis (MVA) do not rely on long particle tracing and are therefore less sensitive to measurement error, but their clinical value in aneurysms is yet to be evaluated.66
Aortic aneurysms, be it abdominal aortic aneurysms (AAAs) or thoracic aortic aneurysms (TAA), are common in the Western Countries' population and often fatal if they rupture.86 Besides flow stasis analysis, particle tracing can be used to assess the blood flow patterns that occur in the aneurysm and help to identify blood flow patterns that might occur in the early stages of aneurysm development.32, 62, 66 Especially in patients at risk for developing aortic aneurysms, such as patients with high blood pressure, high blood cholesterol, or connective tissue disorders such as Marfan syndrome and Ehlers-Danlos syndrome, 4D Flow-based particle tracing could be useful for regular check-ups and risk assessments.37, 87
A study focused on hemodynamics in cerebral aneurysms revealed vortical flow patterns and velocity distributions that are determined by the aneurysm geometry, but more studies are needed to investigate a possible direct link between flow patterns and aneurysm geometries and therefore the clinical value of particle tracing for these diseases.88
The residence time of particles can be useful in anatomies other than aneurysms, such as the heart chambers. A derivative of residence time in the left and right ventricles was significantly correlated with the left and right ventricular ejection fraction, respectively.21 Ventricular residence time can differentiate between patients with systolic dysfunction and healthy volunteers, but further research is still warranted.
INTRACARDIAC PARTICLE TRACING
“Cardiology is Flow,” as flow is both the drive and result of cardiac function.4 And by measuring flow, we can assess cardiac function in a direct approach instead of surrogate markers.4 Myocardial dysfunction, that is, impairment of the heart muscle, can be very subtle, may progress over time, and even lead to heart failure. Lifestyle adjustments such as dietary alterations are suggested to prevent such progression.2 In practice, myocardial dysfunction is defined as having a left ventricular ejection fraction of less than 40%, but flow in the heart is more complex than can be expressed by just ejection fraction. As described below, assessment of the intracardiac flow pattern may be useful in the care of patients with or at risk of cardiac disease. However, it is important to note that besides cardiac disease, some patient characteristics such as age, sex, blood pressure and heart geometry may influence intracardiac flow patterns as well.25 Breathing motion compensation by respiratory gating during MRI acquisition is generally advised, but it may be feasible without.41
MULTICOMPONENT ANALYSIS
- The direct flow component consists of particles that enter the LV through the mitral valve and leave through the aortic valve within a single cardiac cycle.
- The retained inflow component consists of particles that enter the LV through the mitral valve and remain in the LV within a single cardiac cycle.
- The delayed ejection flow component consists of particles that are already in the LV and leave through the aortic valve within a single cardiac cycle.
- The residual volume component consists of particles that are already in the LV and do not leave the LV within a single cardiac cycle.

The four-component analysis compares the size of these components.17 It is important to note that the delayed ejection flow and the retained inflow should theoretically be equal; otherwise the volume of the LV would decrease or increase with each cardiac cycle. The ratio between delayed ejection flow and retained inflow can therefore be used as a quality control of the particle tracing algorithm.24 If valvular regurgitation is expected, a regurgitation component can be added to the analysis.19
The four-component analysis requires the identification of isovolumic contraction. At this timepoint in the cardiac cycle, at the end of diastole and the start of systole, the LV is at its largest (under normal conditions).24 The LV has just started to contract, resulting in the closing of the mitral valve, and the aortic valve has not yet opened. At this time, particles are seeded in all voxels within the LV, for which a segmentation model of the epicardial contour of the LV is needed.24 The particles are then traced forward in time for the duration of the systole to calculate their destination. Then, the particles are also traced backwards in time for the duration of the diastole to calculate their origin.24 Virtual counter planes can be placed over the aortic and mitral valves to count particles that move through these valves. These component analyses can be used to analyze the filling and unloading of other structures, such as the other heart chambers.24
LEFT VENTRICLE
In a scan–rescan study of Stoll et al in 2018, it was shown that there is good reproducibility of the 4D Flow MRI-based four-component analysis in the LV, with the coefficients of variation of a similar magnitude to those of LV volumes derived from cine cardiac MRI.89 This was confirmed by Kamphuis et al in a scan–rescan study in 2018, who found only small (<5%) nonsignificant mean differences for each of the four components.40 In a comparison of the LV four-component analysis in patients with compensated dilated cardiomyopathy and healthy participants, Eriksson et al found a smaller direct flow fraction and altered diastolic flow routes in the patient group, besides the expected larger end-diastolic volume, smaller ejection fraction and equivalent stroke volume in the patient group.90 The flow characteristics, such as kinetic energy, can also be calculated for each component individually and may be useful markers of cardiac failure or give additional insight in cardiac disease, such as univentricular circulation.23, 64 When combined with more refined segmentation models such as the 16-segment LV cavity model, the distribution of components in the individual segments can be measured. This was used to quantitatively analyze the altered LV flow organization after atrioventricular septal defect correction.19 Less direct flow and more retained inflow in the apical and lateral LV cavity segments were shown, and it was hypothesized that this may contribute to decreased cardiac pumping efficiency.19
RIGHT VENTRICLE
In a comparison of the four-component analysis of the right ventricle with the left ventricle, it was found that the direct flow fraction was larger in the right ventricle, while the residual volume was smaller.91 The right ventricular direct flow fraction mostly did not extend to the apical regions but was more located at the basal regions, similar to the left ventricle. In a study that investigated the right ventricle hemodynamics after nitric oxide inhalation in children with pulmonary arterial hypertension, it was suggested that particle tracing may provide more quantitative insights into vasoreactivity testing in pulmonary hypertension than catheterization hemodynamics.52
TETRALOGY OF FALLOT
The venous cardiovascular system, and specifically the venae cavae and the right heart, have been investigated using intracardiac and intravascular particle tracing in patients with congenital heart defects, such as Tetralogy of Fallot (ToF), or patients with Fontan circulation (as described above). In ToF, four defects are present simultaneously, specifically a ventricular septal defect, pulmonary stenosis, over-riding aortic root, and right ventricular hypertrophy. Four-component analysis using particle tracing in patients with repaired ToF and healthy volunteers is significantly different and includes reduced direct flow and increased residual volume.26, 53 Furthermore, increased vortical flow patterns in the right atrium during diastole and increased helical or vortical flow features in the pulmonary arteries were shown in the patients. These vortical flow patterns in the right heart have been shown to be related to pulmonary regurgitation and may represent energy loss.92 Altered flow patterns in the pulmonary arteries have been shown for different surgical techniques, indicating that particle tracing may be useful in identifying optimal surgical strategies.36 Further comprehensive studies using these methods may help understand the interdependencies of geometries and hemodynamics altered post-surgically.26
ATRIA
While the heart ventricles are commonly assessed using the four- or five-component analysis, the atria are often analyzed using methods more similar to intravascular particle tracing by placing seeding grids on the inlets (venae cavae for right atrium; pulmonary veins for left atrium). Visualizing the flow mixing patterns in the atria can be of interest. In the left atrium, vortical flow can be observed during systole and diastolic diastasis and inflow from the left and right pulmonary veins were shown to follow distinct paths throughout the left atrium.34 These flow patterns may be beneficial in preventing left atrial stasis during normal sinus rhythm.34 In mitral regurgitation, left atrial flow is notably different and related to the degree of regurgitation.22
Flow component analysis is also possible, as shown by Gaeta et al, by adjusting the seeding frequency to the velocity per grid point to ensure each particle represents the same volume of blood.35 Blood entering the left atrium could subsequently be categorized into a direct flow component and a retained inflow component, similar to the intracardiac multicomponent analysis described previously. It was shown that blood entering the left atrium during systole mixes with residual blood from the previous heart cycle in a vortex.35
RESEARCH AND NEW APPLICATIONS
Particle tracing is often used as a quality assessment of 4D Flow MRI, for example, in new applications of 4D Flow MRI such as peripheral stents18 or to compare MRI-sequences or postprocessing techniques such as background phase correction.42 The uncertainty of flow patterns as assessed by 4D Flow MRI can also be visualized using a probabilistic particle tracing approach, which may help interpret flow distributions and other probable flow pathways such as plaque movement.27, 28 New cardiovascular surgical techniques may be investigated with 4D Flow MRI-based particle tracing, as demonstrated with an anatomically shaped ascending aortic graft and other ascending aorta surgical techniques.30, 43 Assessment of fetal heart flow patterns with particle tracing was shown to be feasible in sheep, which may open the way to new insights and treatments of congenital heart disease.54
Both 4D Flow MRI and Doppler ultrasound aim to assess the cardiovascular system, but ultrasound has more interobserver and intraobserver variability. 4D Flow MRI-based particle tracing has been used to identify the pitfalls of Doppler evaluation of diastolic function, and may be used for Doppler ultrasound pitfalls in other cardiovascular assessments.33 Additionally, particle tracing can be used to assess whether flow phantoms are comparable to human anatomy.39
Discussion
4D Flow-based particle tracing is an effective tool to visualize time-dependent blood flows and quantify blood flow characteristics. It is intuitive to interpret and gives unique insights into complex flow patterns hitherto impossible to analyze.5, 8 In many cardiovascular applications, 4D Flow-based particle tracing is already feasible and it is included in some medical software packages. However, the technique is limited by inaccuracies, the spatiotemporal resolution of the MRI data, computation time, lack of proof of clinical value and possible suboptimal settings. Particle tracing can be used in the applications shown and with the methods mentioned, but close evaluation of the accuracy and optimal settings of the technique remains advisable.
Current Developments
MRI ACQUISITION IMPROVEMENTS
The clinical value of the technique is driven by its accuracy, which in turn depends heavily on the quality of the MRI data and the settings of the particle tracing technique. The accuracy may also be influenced by the use of contrast agents, and specifically blood pool agents, during acquisition. However, this only resulted in a nonsignificant visual improvement of streamlines and has not been examined with quantitative particle tracing yet.93 4D Flow MRI is a relatively new MRI technique and as such is still being improved. It is expected that these improvements will yield improvements in particle tracing as well.
A defining factor in phase contrast MRI, including 4D Flow MRI, is the encoding velocity venc. This user-defined factor specifies the minimum and maximum velocity that are encoded to the phase and therefore determines the range, contrast and signal-to-noise ratio (SNR) of the velocity-data. In summary, a high venc prevents aliasing for high velocities, but it leads to poor SNR for low velocities. A low venc increases the SNR for low velocities, but aliasing for high velocities. The consensus for 4D Flow MRI is to select a venc of 10% higher than the maximum expected velocity to avoid aliasing, but there is no consensus specifically for particle tracing.8 Additionally, for many cardiovascular structures such as the heart chambers or larger (arterial) vessels, this leads to high SNR in systole, but poor SNR in diastole. New advanced phase contrast MRI sequences have been developed to incorporate multiple venc in the acquisition to give a good SNR for both high and low velocities. When these multi-venc MRI sequences become more available, the average quality and clinical value of particle tracing will be increased. Additionally, multi-venc approaches might lead to new applications of particle tracing that require this broad range of velocities, such as abdominal vasculature. Unfortunately, they require a decrease in temporal resolution or an increase in total acquisition time by adding additional acquisitions.94-97
The acquisition time of 4D Flow MRI can be a limiting factor in practice. This factor is often decreased by increasing the voxel size and decreasing the number of cardiac phases that are acquired. The latter, however, is often already limited by the physical acquisition speed of the scan sequence and the patient's heart rate. With more advanced k-space filling techniques, such as artificial intelligence-driven (AI) approaches, acquisition time can be shortened. This has many advantages, such as increasing the amount of MRI exams that can be done per day. Additionally, this can increase quality by allowing for an increase in spatiotemporal resolution. Accelerated 4D Flow MRI was shown to be feasible using different acceleration factors up to R = 20 times, with minimal differences.38, 46, 49, 59, 98 Using acceleration methods, smaller spatiotemporal resolutions may be achieved which could theoretically improve particle tracing quality drastically, which might be shown in practice in future studies.
POSTPROCESSING IMPROVEMENTS
For some particle tracing methods, such as the intracardiac component particle tracing, a high-quality (4D) segmentation model of the cardiovascular structure is used for seeding and as a boundary to calculate which particles move outside of the structure during the cardiac cycle. Commonly, the endocardial contours are segmented on anatomical cine images such as short-axis or long-axis scans. They are then registered to the 4D Flow MRI scan. Other approaches include AI-based and multi-atlas approaches, which may decrease interobserver and intraobserver error.99 Some of these techniques can even be used directly on the 4D Flow data, removing the necessity for additional anatomical scans, and decreasing scan times. This may lower the threshold for applying particle tracing methods that require segmentation models in the clinic.
A particle tracing timestep is advised to be shorter than the temporal resolution of the MRI data, but the 4D segmentation models have the same temporal resolution as these data. Commonly, a nearest-neighbor approach for the segmentation is used during particle tracing in between cardiac phases of the MRI data. This approach is, however, limited and can cause particles to be wrongfully regarded as outside of the segmentation when traced in between cardiac phases. A shape interpolation method more advanced than a nearest-neighbor interpolation for the segmentation, such as a simple linear or a cubic spline shape interpolation, could improve these issues.
NEW APPLICATIONS
We have shown an extensive summary of vasculature and cardiovascular disease that particle tracing has been applied in. In these applications, particle tracing gives unique insights into flow in the healthy, the diseased, and even the pre-clinical state. However, certainly not all CVDs that can be investigated with particle tracing have been researched thus far. Due to the nature of particle tracing, there is great potential in new applications such as post-operative assessment, thrombosis prediction, preclinical fetal studies, surgical planning, and patient specific implantation development, to name a few.18, 30, 36, 39, 54, 66 Research into particle tracing in these new potential applications will need to be conducted to assess the feasibility and clinical value.
Limitations
This systematic review is limited to articles that mentioned particle tracing and 4D Flow MRI and may therefore miss information that is included in other literature. Alternative phrases such as particle tracking and 3D time-derived phase-contrast MRI were included in the search terms to include different terminology. Particle tracing can be applied in any velocity field and therefore any 4D Flow dataset, but the search terms were chosen to find literature on quantitative particle tracing results rather than just non-quantitative visualization. Other applications of particle tracing may be present in literature missed by this review due to the search terms. Nonetheless, by using two search strategies and including notable related literature, an extensive summary of particle tracing methods and applications has been put together.
Conclusion
In summary, particle tracing based on noninvasive 4D Flow MRI provides unique insights into blood flow. Originally developed for fluid dynamics, it can visualize flow patterns in pulsatile and non-pulsatile blood flows and allows for quantification of flow distributions and flow components. With the summary of methods and applications given in this review, particle tracing can be applied accurately in blood vessels with or without bifurcations and the heart chambers. The accuracy of particle tracing depends heavily on the spatiotemporal resolution and quality of the MRI data. With the future improvements described, 4D Flow-based particle tracing may become more accurate, more versatile, and unveil more about the effect of cardiovascular diseases on blood flow. Further studies are required to evaluate the clinical value of the technique in different cardiovascular diseases.
Acknowledgments
Additional thanks to Hans van Assen, Saša Kenjereš and Arno Roest.